99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients
NCT02744729
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
99mTc-3PRGD2
Sponsor
First Affiliated Hospital of Fujian Medical University